Log in to save to my catalogue

Multifunctional PLGA-based nanoparticles as a controlled release drug delivery system for antioxidan...

Multifunctional PLGA-based nanoparticles as a controlled release drug delivery system for antioxidan...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2207cf04ddaa495eaefd28aee9a1aac1

Multifunctional PLGA-based nanoparticles as a controlled release drug delivery system for antioxidant and anticoagulant therapy

About this item

Full title

Multifunctional PLGA-based nanoparticles as a controlled release drug delivery system for antioxidant and anticoagulant therapy

Publisher

New Zealand: Dove Medical Press Limited

Journal title

International journal of nanomedicine, 2019-01, Vol.14, p.1533-1549

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press Limited

More information

Scope and Contents

Contents

Ischemia/reperfusion (I/R) injury causes the generation of many ROS such as H
O
and leads to vascular thrombosis, which causes tissue damage.
In this investigation, poly (lactideco-glycolide) (PLGA)-based nanoparticles are used for their anticoagulant and antioxidant properties in vascular therapy.
Both heparin and glutathione are entra...

Alternative Titles

Full title

Multifunctional PLGA-based nanoparticles as a controlled release drug delivery system for antioxidant and anticoagulant therapy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2207cf04ddaa495eaefd28aee9a1aac1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2207cf04ddaa495eaefd28aee9a1aac1

Other Identifiers

ISSN

1178-2013,1176-9114

E-ISSN

1178-2013

DOI

10.2147/IJN.S174962

How to access this item